Health ❯ Healthcare ❯ Medical Research

Pharmacology

GLP-1 Receptor Agonists GLP-1 Drugs Diabetes Medications Statins Obesity Treatment Antivenom Development Diabetes Treatment Antibiotic Development Smoking Cessation Geroprotectors Epilepsy Treatment Beta-blockers GLP-1 Medications Renin-Angiotensin System Inhibitors Non-Steroidal Anti-Inflammatory Drugs Anticoagulants PARP Inhibitors Anti-Diabetic Medications Antiseizure Medications Experimental Drugs Drug Treatment Drug Treatments Statin Therapy Diabetes Acetaminophen Antifibrotic Therapy Gabapentin GLP1-RAs Metformin Oseltamivir Obesity Drug Development Glucagon-like Peptide-1 Receptor Agonists Hypertension Hydroxyurea Cancer Research Melatonin Use Melatonin Supplements SGLT Inhibitors Therapies Opioid Research Proton Pump Inhibitors Ovarian Function Migraine Prevention Antidepressants Jet Lag Treatment Drug Mechanisms Weight Loss Drugs Polymethylmethacrylate (PMMA) Acetaminophen Overdose

Mounjaro Study Finds Lower Heart‑Attack Risk as UK Safety Reports Rise

Officials say Yellow Card reports do not prove drugs caused harm.

Study Finds Small Rise in Smell and Taste Diagnoses Among People on GLP‑1 Diabetes Drugs

GLP‑1 Agonists Linked to Lower Clot Risk and Mortality in People With Obesity and Autoimmune Disease

Migraine CGRP Drugs Tied to Lower Glaucoma Risk in Neurology Study

Mouse Study Finds Semaglutide Directly Reprograms Liver Cells to Ease Disease Without Weight Loss

Antidepressant Fluvoxamine Eases Long COVID Fatigue in Randomized Trial

Studies Link GLP-1 Drugs to Lower Addiction and Overdose Risks

Heart Risks Rebound After GLP-1 Breaks, New Data Show Continuous Use Is Safest

Nature Papers Reveal 'Reverse' GPCR Switch That Boosts Opioid Analgesia in Preclinical Tests

Meta-Analysis Finds GLP-1 Drugs Show Little Short-Term Impact on Obesity-Linked Cancer Risk

JAMA Meta-Analyses at Kidney Week Back Routine SGLT2 Inhibitors Across Kidney Function

Long-Term Melatonin Use Linked to Higher Heart Failure and Mortality Risk in Large EHR Study

GLP-1 Drugs Linked to Lower Overall Cancer Risk in JAMA Oncology Analysis

Peer-Reviewed OU Study Maps Amylin Receptors, Offering Tools for Next‑Gen Obesity Drugs

Metformin Linked to Lower Dementia and Mortality Risks in Overweight, Obese Adults

Frequent Gabapentin Prescriptions Tied to Increased Dementia and Cognitive Impairment Risk

Statins Linked to 39% Drop in 28-Day Mortality for Sepsis Patients

GLP-1 Agonists Tied to Higher Risk of Macular Degeneration and Rare Optic Neuropathy

Cancer drug pair extends mouse lifespan by 30% as researchers plan human trials

GLP-1 Drugs Linked to Lower Cancer Risk and Mortality in New Study